Skip to content

A Randomized Controlled Study for Shock Wave Therapy Combined with Wax Therapy in the Treatment of External Humeral Epicondylitis

A Randomized Controlled Study for Shock Wave Therapy Combined with Wax Therapy in the Treatment of External Humeral Epicondylitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021398
Enrollment
Unknown
Registered
2019-02-19
Start date
2019-02-25
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

External epicondylitis of humerus

Interventions

Shock wave group:Dispersive extracorporeal shock wave therapy
Wax therapy group:External application of wax block
Combined group:Shock wave therapy plus wax therapy

Sponsors

The First Hospital of Harbin City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. To meet the clinical diagnostic criteria for lateral epicondylitis of humerus; 2. X-ray examination showed no positive findings; 3. Mills sign positive and Cozen sign positive; 4. Patients did not receive other conservative treatment or non-surgical treatment in the recent three months; 5. Patients agreed to participate in the trial and willing to follow up for a long time after operation, and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Elbow canal syndrome, bone tumors, olecranon injury, epiphysitis of humerus, osteomyelitis, tuberculosis of humerus, supracondylar fracture of humerus and other non-tendon-injured elbow diseases; 2. Elimination of diseases and psychiatric diseases accompanied by severe circulatory system, endocrine system, nervous system; 3. Local skin infection and ulceration, drug allergy; 4. Patients with local injection therapy within 3 weeks; 5. Pregnant, breast-feeding or recent family planning; 6. Patients with poor compliance, can not cooperate with the completion of the treatment process, or combined with other methods of treatment.

Design outcomes

Primary

MeasureTime frame
Visual analog scale;

Countries

China

Contacts

Public ContactBaolin Li

The First Hospital of Harbin City

baoli06@163.com+86 18249514430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026